Navigation Links
Large Vein Occlusive Disease: Diagnosis and Treatment Options to be Presented at the 40th Annual VEITHsymposium in New York
Date:11/20/2013

el venous occlusion affords opportunities for the patient and the vascular practitioner alike.  Newly gained knowledge of the disease and the results of treatment can be applied to a larger proportion of the underserved population with venous disease; at the same time expanding the armamentarium of effective interventions available to the practicing clinician."  

     Experts will address the unmet needs and opportunities for the future, other commonly encountered venous occlusive problems and their treatment, treatment of lower extremityDVT, balloons, stents, thrombolysis, ultrasound thrombolysis, mechanical thrombectomy, and inferior vena caval issues (including endovascular and open surgical management). 

     About VEITHsymposium: Now in its fourth decade, VEITHsymposium provides vascular surgeons, interventional radiologists, interventional cardiologists and other vascular specialists with a unique and exciting format to learn the most current information about what is new and important in the treatment of vascular disease. The 5-day event features over 750 rapid-fire presentations from world-renowned vascular specialists with emphasis on the latest advances, changing concepts in diagnosis and management, pressing controversies and new techniques. To register to attend the VEITHsymposium, please visit www.VEITHpress.org or contact Pauline T. Mayer at 631.979.3780 or email.

Media Contact: Pauline Mayer, PTM Healthcare Marketing, Inc., 631-979-3780, ptm@ptmhcm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE VEITHsymposium
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ViGene Biosciences Introduces Worlds Largest Collection of Pre-Made Human Full-Length cDNA ORF and miRNA Adenoviruses
2. Does Your Business Have the Tools to Compete in the Worlds Largest Diagnostics Markets?
3. Volcano Announces Upcoming Data Presentations from Large-Scale Studies on Physiology and Imaging Technologies at TCT 2013
4. DNA Diagnostics Center (DDC), One of the Worlds Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%
5. B. Braun Receives FDA Approval For New Large-Volume Irrigation Containers
6. B. Braun Receives FDA Approval For New Large-Volume Intravenous Containers
7. Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
8. ResearchMoz.us: Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity
9. Large-Scale Global Registry to Examine Treatment Patterns and Disease Burden Among Patients with Venous Thromboembolism (VTE)
10. SERVE-HF; the Worlds Largest Study of Sleep-Disordered Breathing in Heart Failure Completes Recruitment
11. Large-Scale Kaiser Permanente Program Linked to Improved Blood Pressure Control
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015 Pulse Light ... a survey to Rosacea sufferers as part of their ongoing ... Rosacea sufferers found effective for their Rosacea. The survey participants ... comprised 47% men and 53% women. The results ... participants did not consider or attempt to visit their GP ...
(Date:6/30/2015)... , June 30, 2015  Ardelyx, Inc. (NASDAQ: ... cardio-renal, gastrointestinal and metabolic diseases, today announced that the ... 14, 2015, from 8:00 a.m.- 1:00 pm EDT in ... The Ardelyx senior management team will present an ... compound, tenapanor, which has completed Phase 2b clinical trials ...
(Date:6/30/2015)... , BERKELEY, Kalifornien, und KOPENHAGEN, Dänemark, ... Biologics, Inc. , ein Weltmarktführer der klinischen ... anderen therapeutischen Proteinen, gab heute bekannt, dass ... der Produktionskapazität den Ausbau der nordamerikanischen Produktionsanlage ... mit der Ergänzung  einer Einweg-Anlage Bioreactor 6Pack™ ...
Breaking Medicine Technology:84% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 284% of Rosacea Sufferers Say NHS Treatments Were "Ineffective" New Survey Reveals 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 2CMC Biologics baut GMP-Produktionskapazität in den USA aus 3
... Mass., Oct. 26, 2011 Idenix Pharmaceuticals, Inc. (NASDAQ: ... financial results for the third quarter of 2011 on Wednesday, ... Idenix management will host a conference call at 4:30 p.m. ... financial results for the third quarter of 2011 and provide ...
... MECHANICSBURG, Pa., Oct. 26, 2011 One out of three ... according to an Opinion Research/Select Medical telephone poll. Against that ... a statement today reminding the American public that influenza season ... chronic lung disease such as asthma or COPD (Chronic Obstructive ...
Cached Medicine Technology:Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD) 2Poll: One Out of Three U.S. Adults Not Planning to Get Flu Shot This Year 2
(Date:6/30/2015)... ... June 30, 2015 , ... ... Rehab”. The video focuses on the rehab center’s patients and their experiences at ... the best quality of services available. Each patient attests to the high rating, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Broadway by the Sea posted its ... and family member testimonials. Medicare rated the care center as a five-star location based ... video to give future patients a firsthand look at the facility’s satisfied residents. ...
(Date:6/30/2015)... ... June 30, 2015 , ... The progress of ... multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana, ... to the Court’s calendar, that conference has now been scheduled for July 9th, ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... ... community. , Eleven physicians from Allied’s Fullerton division volunteered to help provide free ... Super Surgery Saturday, March 21, at St. Jude Medical Center. , The ...
(Date:6/30/2015)... ... June 30, 2015 , ... Red Hot & Blue Restaurants, ... online poll at http://scoutology.com/novaburgerwars and was selected as “Best BBQ” in a ... 2015. , Red Hot & Blue President Randy McCann said, “Everyone knows Red Hot ...
Breaking Medicine News(10 mins):Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3
... Nov. 6, 2008 Advanced age and race are ... dies or suffers a stroke after carotid-artery surgery, a ... found. , "This study identified 11 readily available, ... surgeons and anesthesiologists better weigh the risks and benefits ...
... The Content of His Character ... Statement of Lorraine Cole, Ph.D., YWCA ... ... had the privilege of,conducting an oral history interview with Dr. Dorothy Height, who ... her move to New York to take that position, she served as the,Executive ...
... Percent Increase in IVUS System Sales, SAN DIEGO, ... a leader in the development, manufacturing and sales of,products ... artery,disease, today reported that revenues for the third quarter ... quarter of 2007., For the quarter ended September ...
... Share of $0.32 and Contract Value of $230.6 million; Announces New Program ... ... Board Company,(Nasdaq: ABCO ) today announced financial results for the second quarter ... $57.6 million, from $54.0 million in the second quarter of fiscal 2008.,Net income ...
... Ind., Nov. 5 Conseco, Inc. (NYSE:,CNO) today ... "We are pleased,with the performance of our core ... "with income before net realized investment losses,corporate interest ... the,favorable end of the estimated ranges we provided ...
... Nov. 5 The American Dental,Association (ADA) continues to ... the 2008 Golden Apple Awards. The Golden Apple,Awards program, ... society activities and excellence in leadership., The 2008 ... of the,year to the following societies:, -- ...
Cached Medicine News:Health News:Age, race are among factors that influence carotid-surgery success 2Health News:YWCA USA Recognizes Historic Election Milestone 2Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 2Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 3Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 4Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 5Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 6Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 7Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 8Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 9Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 10Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 11Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 12Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 13Health News:Volcano Reports 40 Percent Growth in Quarterly Revenues 14Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 2Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 3Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 4Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 5Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 6Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 7Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 8Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 9Health News:The Advisory Board Company Reports Fiscal Year 2009 Second Quarter Results 10Health News:Conseco Reports Third Quarter Results 2Health News:Conseco Reports Third Quarter Results 3Health News:Conseco Reports Third Quarter Results 4Health News:Conseco Reports Third Quarter Results 5Health News:Conseco Reports Third Quarter Results 6Health News:Conseco Reports Third Quarter Results 7Health News:Conseco Reports Third Quarter Results 8Health News:Conseco Reports Third Quarter Results 9Health News:Conseco Reports Third Quarter Results 10Health News:Conseco Reports Third Quarter Results 11Health News:Conseco Reports Third Quarter Results 12
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: